Towa Pharmaceutical Co (JP:4553) has released an update.
Towa Pharmaceutical Co. has revised its financial forecasts upward for the fiscal year ending March 31, 2025, driven by strong overseas sales and lower-than-expected R&D expenses. The company now expects significant increases in profits and earnings per share due to favorable foreign exchange gains and operational efficiency.
For further insights into JP:4553 stock, check out TipRanks’ Stock Analysis page.
Trending Articles:
Questions or Comments about the article? Write to editor@tipranks.com